#METABOLOMICS WORKBENCH lgafeira_20230913_021756 DATATRACK_ID:4312 STUDY_ID:ST002868 ANALYSIS_ID:AN004701 PROJECT_ID:PR001791
VERSION             	1
CREATED_ON             	September 13, 2023, 3:02 am
#PROJECT
PR:PROJECT_TITLE                 	Pathogenic Staphylococcus epidermidis ICE25 response to skin and blood pH
PR:PROJECT_TYPE                  	Proteomic and metabolomic study
PR:PROJECT_SUMMARY               	Staphylococcus epidermidis (SE) is one of the most common bacteria of the human
PR:PROJECT_SUMMARY               	skin microbiota. Despite its role as a commensal, SE has emerged as an
PR:PROJECT_SUMMARY               	opportunistic pathogen, associated with 80% of medical devices related
PR:PROJECT_SUMMARY               	infections. Moreover, these bacteria are extremely difficult to treat due to
PR:PROJECT_SUMMARY               	their ability to form biofilms and accumulate resistance to almost all classes
PR:PROJECT_SUMMARY               	of antimicrobials developed so far. Thus new preventive and therapeutic
PR:PROJECT_SUMMARY               	strategies are urgently needed. In spite of its clinical importance, the
PR:PROJECT_SUMMARY               	molecular mechanisms associated with SE colonisation and disease are still
PR:PROJECT_SUMMARY               	poorly understood. A deeper understanding of the metabolic and cellular
PR:PROJECT_SUMMARY               	processes associated with response to environmental factors characteristic of SE
PR:PROJECT_SUMMARY               	ecological niches in health and disease might provide new clues on colonisation
PR:PROJECT_SUMMARY               	and disease processes. Here we studied the impact of pH conditions, mimicking
PR:PROJECT_SUMMARY               	the skin pH (5.5) and blood pH (7.4), in a S. epidermidis pathogenic strain,
PR:PROJECT_SUMMARY               	belonging to the A/C clonal lineage, by means of next-generation proteomics and
PR:PROJECT_SUMMARY               	1H NMR-based metabolomics. Moreover, we evaluated the metabolic changes
PR:PROJECT_SUMMARY               	occurring when a sudden pH change arise, simulating the skin barrier break
PR:PROJECT_SUMMARY               	produced by a catheter.
PR:INSTITUTE                     	ITQB NOVA
PR:LAST_NAME                     	Gonçalves
PR:FIRST_NAME                    	Luís
PR:ADDRESS                       	Avenida Republica, Oeiras, Not USCanada, 2780-157 Oeiras, Portugal
PR:EMAIL                         	lgafeira@itqb.unl.pt
PR:PHONE                         	214469464
#STUDY
ST:STUDY_TITLE                   	Pathogenic Staphylococcus epidermidis ICE25 response to skin and blood pH
ST:STUDY_SUMMARY                 	Staphylococcus epidermidis (SE) is one of the most common bacteria of the human
ST:STUDY_SUMMARY                 	skin microbiota. Despite its role as a commensal, SE has emerged as an
ST:STUDY_SUMMARY                 	opportunistic pathogen, associated with 80% of medical devices related
ST:STUDY_SUMMARY                 	infections. Moreover, these bacteria are extremely difficult to treat due to
ST:STUDY_SUMMARY                 	their ability to form biofilms and accumulate resistance to almost all classes
ST:STUDY_SUMMARY                 	of antimicrobials developed so far. Thus new preventive and therapeutic
ST:STUDY_SUMMARY                 	strategies are urgently needed. In spite of its clinical importance, the
ST:STUDY_SUMMARY                 	molecular mechanisms associated with SE colonisation and disease are still
ST:STUDY_SUMMARY                 	poorly understood. A deeper understanding of the metabolic and cellular
ST:STUDY_SUMMARY                 	processes associated with response to environmental factors characteristic of SE
ST:STUDY_SUMMARY                 	ecological niches in health and disease might provide new clues on colonisation
ST:STUDY_SUMMARY                 	and disease processes. Here we studied the impact of pH conditions, mimicking
ST:STUDY_SUMMARY                 	the skin pH (5.5) and blood pH (7.4), in a S. epidermidis pathogenic strain,
ST:STUDY_SUMMARY                 	belonging to the A/C clonal lineage, by means of next-generation proteomics and
ST:STUDY_SUMMARY                 	1H NMR-based metabolomics. Moreover, we evaluated the metabolic changes
ST:STUDY_SUMMARY                 	occurring when a sudden pH change arise, simulating the skin barrier break
ST:STUDY_SUMMARY                 	produced by a catheter.
ST:INSTITUTE                     	ITQB NOVA
ST:LAST_NAME                     	Gonçalves
ST:FIRST_NAME                    	Luís G.
ST:ADDRESS                       	Avenida Republica
ST:EMAIL                         	lgafeira@itqb.unl.pt
ST:PHONE                         	214469464
#SUBJECT
SU:SUBJECT_TYPE                  	Bacteria
SU:SUBJECT_SPECIES               	Staphylococcus epidermidis
SU:TAXONOMY_ID                   	1282
SU:GENOTYPE_STRAIN               	Staphylococcus epidermidis ICE25
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	SE_1_190530	Class:I77	RAW_FILE_NAME=SE_1_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_10_190530	Class:I57	RAW_FILE_NAME=SE_10_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_11_190530	Class:I57	RAW_FILE_NAME=SE_11_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_18_190530	Class:I55	RAW_FILE_NAME=SE_18_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_23_190530	Class:I55	RAW_FILE_NAME=SE_23_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_24_190530	Class:I55	RAW_FILE_NAME=SE_24_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_4_190530	Class:I57	RAW_FILE_NAME=SE_4_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_5_190530	Class:I77	RAW_FILE_NAME=SE_5_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_6_190530	Class:I77	RAW_FILE_NAME=SE_6_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_7_190530	Class:I57	RAW_FILE_NAME=SE_7_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_9_190530	Class:I77	RAW_FILE_NAME=SE_9_190530
SUBJECT_SAMPLE_FACTORS           	-	SE_a03_190712	Class:I57	RAW_FILE_NAME=SE_a03_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a04_190712	Class:I55	RAW_FILE_NAME=SE_a04_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a06_190712	Class:I77	RAW_FILE_NAME=SE_a06_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a07_190712	Class:I55	RAW_FILE_NAME=SE_a07_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a09_190712	Class:I57	RAW_FILE_NAME=SE_a09_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a11_190712	Class:I55	RAW_FILE_NAME=SE_a11_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a12_190712	Class:I77	RAW_FILE_NAME=SE_a12_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a13_190712_rep	Class:I57	RAW_FILE_NAME=SE_a13_190712_rep
SUBJECT_SAMPLE_FACTORS           	-	SE_a16_190712	Class:I77	RAW_FILE_NAME=SE_a16_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a17_190712	Class:I57	RAW_FILE_NAME=SE_a17_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a18_190712	Class:I55	RAW_FILE_NAME=SE_a18_190712
SUBJECT_SAMPLE_FACTORS           	-	SE_a20_190712	Class:I77	RAW_FILE_NAME=SE_a20_190712
#COLLECTION
CO:COLLECTION_SUMMARY            	The Staphylococcus epidermidis 19N strain was collected from the anterior nares
CO:COLLECTION_SUMMARY            	of a healthy person in Portugal in 2001. This strain was previously
CO:COLLECTION_SUMMARY            	characterised by whole genome sequencing and belongs to clonal lineage B. A
CO:COLLECTION_SUMMARY            	single colony from a S. epidermidis 19N strain culture grown O/N at 37ºC (TSA,
CO:COLLECTION_SUMMARY            	BactoTM), was used to pre-inoculate Tryptic Soy Broth (TSB) medium with two
CO:COLLECTION_SUMMARY            	different pH (5.5 and 7.4) that was incubated overnight at 37ºC under
CO:COLLECTION_SUMMARY            	agitation. Pre-inoculums were adjusted either to pH 5.5 or pH 7.4, with
CO:COLLECTION_SUMMARY            	hydrochloric acid. In this work, three pH transitions from pre-inoculum to
CO:COLLECTION_SUMMARY            	inoculum were assayed. S. epidermidis pre-inoculums and the growth were
CO:COLLECTION_SUMMARY            	performed at medium with pH 7.4, to mimic the blood pH; and pH 5.5, to mimic the
CO:COLLECTION_SUMMARY            	skin pH. The pre-inoculum cellular density was adjusted to 0.06 (OD600)
CO:COLLECTION_SUMMARY            	(aprox.1.5x108 CFU/mL) and used to inoculate fresh medium in the three
CO:COLLECTION_SUMMARY            	conditions depicted in Figure 1, simulating S. epidermidis at skin and blood and
CO:COLLECTION_SUMMARY            	a pH shock endured by S. epidermidis during the infection process from skin to
CO:COLLECTION_SUMMARY            	blood transition. The cell cultures incubated at 37ºC with 225 rpm were
CO:COLLECTION_SUMMARY            	followed by OD600 and recovered at mid-exponential phase for further analysis.
CO:SAMPLE_TYPE                   	Staphylococcus epidermidis intracellular
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	n this work, three pH transitions from pre-inoculum to inoculum were assayed. S.
TR:TREATMENT_SUMMARY             	epidermidis pre-inoculums and the growth were performed at medium with pH 7.4,
TR:TREATMENT_SUMMARY             	to mimic the blood pH; and pH 5.5, to mimic the skin pH. The pre-inoculum
TR:TREATMENT_SUMMARY             	cellular density was adjusted to 0.06 (OD600) (aprox.1.5x108 CFU/mL) and used to
TR:TREATMENT_SUMMARY             	inoculate fresh medium in the three conditions depicted in Figure 1, simulating
TR:TREATMENT_SUMMARY             	S. epidermidis at skin and blood and a pH shock endured by S. epidermidis during
TR:TREATMENT_SUMMARY             	the infection process from skin to blood transition. The cell cultures incubated
TR:TREATMENT_SUMMARY             	at 37ºC with 225 rpm were followed by OD600 and recovered at mid-exponential
TR:TREATMENT_SUMMARY             	phase for further analysis. Pre-inocula were prepared in TSB medium at pH 5.5 or
TR:TREATMENT_SUMMARY             	7.4. Inocula at pH 5.5 was used for the cultures grown at 5.5 (N55) and 7.4
TR:TREATMENT_SUMMARY             	(N57), and the inoculum at pH 7.4 for the culture at the same pH (N77). The
TR:TREATMENT_SUMMARY             	cells were harvested at mid-exponential phase.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Cells were recovered at mid-exponential phase from 100 mL cultures following a
SP:SAMPLEPREP_SUMMARY            	protocol adapted from Somerville & Powers (Somerville and Powers 2014). Eight
SP:SAMPLEPREP_SUMMARY            	biological replicates of each independent growth condition were obtained. Cells
SP:SAMPLEPREP_SUMMARY            	were harvested by centrifugation at 5000 x g for 5 min at 4ºC. Cells were
SP:SAMPLEPREP_SUMMARY            	washed with 20 mM phosphate buffer pH 7.2-7.4 and centrifuged for 1 min at
SP:SAMPLEPREP_SUMMARY            	13,000 rpm. Cell pellet was suspended in the same buffer with a final OD600 of
SP:SAMPLEPREP_SUMMARY            	20 and stored at -80ºC for further metabolite extraction. Cells were thawed in
SP:SAMPLEPREP_SUMMARY            	a water bath at room temperature and 750 µL of 60% methanol were added and
SP:SAMPLEPREP_SUMMARY            	subjected to three freeze-thaw cycles using liquid nitrogen. Extracted samples
SP:SAMPLEPREP_SUMMARY            	were centrifuged at 21,000 g for 5 min at 4ºC. The extraction process on the
SP:SAMPLEPREP_SUMMARY            	pellets was repeated twice. The supernatants were kept and stored together at
SP:SAMPLEPREP_SUMMARY            	-20ºC overnight and dried in a SpeedVac. Dried samples were dissolved in: 750
SP:SAMPLEPREP_SUMMARY            	µL phosphate buffer (33 mM, pH 7.0 in D2O with 2 mM of sodium azide) with 0.21
SP:SAMPLEPREP_SUMMARY            	mM of 3-(trimethylsilyl)propionic-2,2,3,3-d4 (TSP). The suspensions were
SP:SAMPLEPREP_SUMMARY            	centrifuged at 21,000 g for 5 min at 4ºC and the resulting supernatants were
SP:SAMPLEPREP_SUMMARY            	then transferred to 5 mm NMR tubes.
#ANALYSIS
AN:ANALYSIS_TYPE                 	NMR
#NMR
NM:INSTRUMENT_NAME               	Bruker Avance II+ 800 MHz
NM:INSTRUMENT_TYPE               	FT-NMR
NM:NMR_EXPERIMENT_TYPE           	1D-1H
NM:SPECTROMETER_FREQUENCY        	800
NM:NMR_PROBE                     	5 mm TXI-Z H/C/N/-D
NM:NMR_SOLVENT                   	D2O
NM:NMR_TUBE_SIZE                 	5 mm
NM:SHIMMING_METHOD               	Topshim
NM:CHEMICAL_SHIFT_REF_CPD        	TSP
NM:TEMPERATURE                   	25
#NMR_METABOLITE_DATA
NMR_METABOLITE_DATA:UNITS	nanomoles
NMR_METABOLITE_DATA_START
Samples	SE_18_190530	SE_23_190530	SE_24_190530	SE_a04_190712	SE_a07_190712	SE_a11_190712	SE_a18_190712	SE_10_190530	SE_11_190530	SE_4_190530	SE_7_190530	SE_a03_190712	SE_a09_190712	SE_a13_190712_rep	SE_a17_190712	SE_1_190530	SE_5_190530	SE_6_190530	SE_9_190530	SE_a06_190712	SE_a12_190712	SE_a16_190712	SE_a20_190712
Factors	Class:I55	Class:I55	Class:I55	Class:I55	Class:I55	Class:I55	Class:I55	Class:I57	Class:I57	Class:I57	Class:I57	Class:I57	Class:I57	Class:I57	Class:I57	Class:I77	Class:I77	Class:I77	Class:I77	Class:I77	Class:I77	Class:I77	Class:I77
2-Hydroxyisobutyrate	2.625	3.9	4.125	4.275	2.625	1.5	1.425	0.9	0.675	0.825	0.6	0.675	3.15	3.975	2.7	1.425	1.2	1.2	1.2	1.35	2.475	2.25	1.425
3-Hydroxyisovalerate	3.675	3.525	3.525	9.675	10.2	2.85	2.1	4.95	5.325	4.575	4.8	10.5	9.375	2.1	10.575	3.3	3.225	4.425	4.35	10.425	2.325	10.875	2.925
AMP	4.2	6.375	8.625	17.1	14.85	17.175	15.45	15.225	11.55	14.25	16.95	18.375	13.425	12.6	12.825	22.95	21.9	11.775	17.85	20.025	18.225	19.8	21.075
Acetate	43.875	35.175	67.425	65.775	58.65	53.175	59.775	30.3	36.525	43.8	32.775	39.825	51.9	39.75	37.95	61.125	48.9	54.6	52.275	71.4	125.025	116.025	75.75
Adenine	3.15	4.275	4.35	7.725	4.425	4.5	10.575	3.75	1.875	4.05	6.225	6.6	5.7	5.55	4.35	7.05	4.575	9.075	5.025	14.25	17.4	18.075	13.725
Adenosine	3.15	6.75	11.25	21.3	15.225	16.2	17.55	14.175	13.2	16.8	14.4	14.85	12.9	11.625	16.575	22.8	21.075	14.175	21.45	22.425	25.275	20.1	23.025
Alanine	10.275	20.1	27.15	50.7	47.475	40.2	54.675	33.675	23.475	22.275	36.9	39.9	24.825	24	35.025	111.825	42.9	36.3	51	73.65	101.925	87.975	83.325
Arabinose	1.65	4.35	3.6	9.525	5.625	7.275	8.175	0.75	2.25	3.6	2.85	3.975	4.125	1.65	3.525	11.175	14.625	19.125	11.25	13.65	12.3	24.225	13.95
Asparagine	13.425	19.5	24.6	19.95	17.625	14.1	19.725	11.175	8.1	14.1	11.85	18.075	8.7	12	10.05	12	13.95	13.725	18.75	18.675	13.8	14.55	21.375
Aspartate	94.875	116.1	139.425	190.65	167.175	191.925	170.475	254.1	263.025	331.125	327.225	368.4	194.775	201.975	240.6	154.65	180.9	142.725	149.4	206.1	163.35	187.425	241.5
Betaine	314.85	490.5	560.4	757.8	504.975	586.125	550.5	154.2	159.525	267.45	364.125	532.575	278.175	258.525	404.4	256.425	237.975	297.225	305.4	377.25	315.225	354.675	493.5
Choline	14.925	22.65	31.275	44.1	25.2	29.55	33.45	4.125	4.125	6.6	8.1	9.9	4.875	5.325	8.475	9.675	7.575	9.675	10.95	10.95	10.35	9.9	13.275
Coenzyme A	2.325	15.75	20.025	2.85	9.75	15.975	4.575	17.1	31.725	8.4	5.55	20.85	6.075	2.1	5.85	12	16.8	15.225	9.675	7.725	16.65	5.1	5.55
Cytidine monophosphate	3.675	5.55	7.35	30.9	24.45	21.45	22.35	13.2	8.325	11.025	13.725	20.325	11.775	10.275	18.375	25.575	14.7	12.9	25.05	32.175	27.3	29.85	31.425
Formate	22.05	23.25	22.65	105.6	100.275	92.55	84.075	18.525	23.55	21.675	23.85	65.625	71.175	67.65	86.85	25.8	23.925	23.475	18.675	65.775	56.7	47.1	56.1
Glucose	0	0	10.95	0	0	0	0	3.675	1.35	0	0	0	0	0	0	14.55	5.55	4.725	3.375	0	0	0	0
Glutamate	325.2	437.7	498.9	590.325	470.475	532.95	515.4	250.125	263.1	294.375	315.225	422.175	267.6	277.725	289.65	568.5	528.9	507.675	544.2	495	439.875	525.375	549.75
Glutamine	45.075	65.7	99.675	68.1	54.075	54.45	49.05	15.9	11.025	0	19.125	31.425	22.8	25.2	20.175	0	23.4	21.525	20.625	22.2	20.25	25.8	32.55
Glycine	0.375	0.45	25.65	0.75	0.75	0.375	0.75	0.675	0.9	0.9	0.75	0.9	1.425	1.2	1.8	7.8	7.5	1.425	0.9	1.95	1.2	2.175	2.025
Guanosine	1.125	1.575	1.35	3.525	3.3	3.75	4.575	4.35	3.225	7.875	6	5.55	3.3	3.15	5.025	6.675	8.775	6.75	10.35	5.4	3.45	5.55	5.325
Histidine	0.9	2.1	2.175	4.35	3.3	4.275	3.9	2.4	1.725	2.325	2.925	3.45	2.175	1.95	3.15	4.725	3.675	3.3	5.1	3.975	4.2	4.35	4.2
Isoleucine	1.5	2.775	4.05	4.5	2.625	3.225	2.55	1.95	1.725	2.625	3.075	3.45	1.95	2.25	2.475	5.4	3.75	3.45	4.2	3.525	5.025	4.125	4.8
Isovalerate	1.125	0.975	1.8	3.45	3.525	3.15	3.3	0.675	1.2	1.275	0.825	1.2	1.275	0.9	0.825	0.9	1.2	1.2	1.05	3.3	3.075	3.375	2.55
Lactate	6.9	25.95	28.8	29.25	6.975	24.75	6.45	11.325	13.425	10.275	12.9	6.375	24.525	12.45	9.975	64.875	19.2	26.625	33.45	17.4	90.15	36.15	28.5
Leucine	7.575	11.925	15.9	16.875	11.7	14.1	12.975	6.975	6.225	8.7	10.8	13.575	8.85	9.15	10.35	17.475	13.125	11.775	16.5	13.875	19.575	15.825	17.55
Lysine	4.725	7.425	8.25	12.45	9.15	11.85	17.7	11.55	8.925	13.875	13.8	13.05	7.125	8.025	12.975	24.975	19.575	18.375	21.3	20.775	22.95	21	20.475
NAD+	11.55	11.55	17.7	3.3	10.875	11.55	13.95	14.7	14.925	19.05	14.7	15.525	11.475	11.175	12.075	18.75	20.55	17.175	21.9	2.025	16.275	14.175	3.9
NADP+	3.3	2.925	4.5	2.4	2.775	2.325	3	4.725	4.575	6.75	4.8	5.175	4.275	3.825	4.65	5.55	6.525	5.625	7.275	4.65	4.95	5.025	5.25
Nicotinate	1.575	3.525	1.35	3.075	2.775	3	2.4	2.1	3.225	0	3.075	4.575	2.1	2.55	4.575	3.75	1.2	0.825	1.125	3.975	3.75	5.55	4.125
Phenylalanine	3.6	5.625	7.725	8.85	7.5	8.475	7.35	4.875	5.025	6.75	7.35	9.075	5.55	5.85	7.8	10.125	7.875	6.75	8.25	7.875	8.4	9.75	9.225
Phosphoenolpyruvic acid	7.875	10.65	8.775	10.35	8.1	8.025	5.625	5.475	5.7	9.225	11.475	6.525	4.725	3.6	7.125	9.525	8.25	9.375	10.875	12.45	9.675	8.4	11.25
Succinate	8.1	9.675	12.15	22.725	20.325	23.025	22.275	7.35	7.95	9.45	9.6	12.375	8.4	9.225	8.925	15.225	12.9	14.025	14.55	22.05	21.75	22.8	21.15
Sucrose	0	1.425	115.725	1.575	0.9	1.05	1.05	0	0	0	0	0	2.025	2.775	2.325	43.2	1.125	1.2	1.425	0	0	1.95	0
Threonine	3.225	6.675	17.775	23.1	9.9	4.95	2.55	2.4	3.375	2.175	3.225	3.3	1.65	2.025	1.8	4.725	6.975	5.025	8.925	2.85	7.95	6.75	9.3
Tryptophan	0	1.125	0	1.2	0.825	1.275	1.35	1.425	0	1.425	0.9	0.6	0	0.825	1.95	2.025	1.425	1.5	1.8	1.875	2.7	3.3	1.65
Tyrosine	0.375	0.6	0.75	1.875	1.125	1.5	1.2	0.75	0.9	0.45	0.9	2.025	0.825	1.125	1.725	2.025	0.975	1.2	1.65	1.875	2.4	3.3	2.25
UMP	2.925	1.8	3.525	14.025	11.55	11.85	11.775	7.95	5.4	6.15	9.45	12.075	5.625	4.8	9.9	11.85	7.2	8.625	11.775	11.1	9	11.625	13.725
Uracil	0.825	1.575	2.85	13.125	9.375	11.025	14.775	2.025	0.825	1.875	1.65	5.4	2.55	2.7	3.9	3.675	1.425	2.85	4.2	11.325	11.625	12.75	10.05
Uridine	0.75	1.575	2.475	3.975	4.125	4.5	6.375	3.525	2.175	2.475	3.6	3.675	2.4	2.25	3.75	5.475	2.4	5.25	5.625	3.9	6.675	4.875	5.025
Valine	2.4	3.975	6.225	9.3	7.125	8.475	6.75	2.925	2.7	3.75	4.725	5.55	2.925	3	3.825	7.35	5.4	5.1	6.075	6.75	7.725	6.75	7.5
sn-Glycero-3-phosphocholine	40.05	56.775	60.675	10.875	40.35	41.325	38.85	13.2	15.3	16.05	17.175	19.425	15.3	15.825	18.225	19.95	16.125	17.175	20.025	12.3	15.075	14.1	16.725
beta-Alanine	2.475	4.65	4.05	6.075	8.7	7.575	10.875	5.325	3.75	8.925	6.3	4.65	5.175	4.425	4.35	7.65	8.55	10.35	7.575	9.6	8.025	12.75	9.9
Cystathionine	0	0	0	0	3.825	4.125	0	9.6	9.3	9.225	10.275	26.25	25.8	22.95	24.825	11.55	11.1	9	9.225	12.45	14.4	12.675	14.4
NMR_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	RefMet Name/Standardized Name*	WorkBench	PubChem	Kegg Id
2-Hydroxyisobutyrate	2-Hydroxyisobutyric acid	ME545925	11671	NA
3-Hydroxyisovalerate	3-Hydroxyisovaleric acid	ME545926	69362	C20827
Acetate	Acetic acid	ME545928	176	C00033
Adenine	Adenine	ME545929	190	C00147
Adenosine	Adenosine	ME545930	60961	C00212
Alanine	Alanine	ME545931	5950	C00041
AMP	AMP	ME545927	6083	C00020
Arabinose	Arabinose	ME545932	439195	C02479
Asparagine	Asparagine	ME545933	6267	C00152
Aspartate	Aspartic acid	ME545934	5960	C00049
beta-Alanine	beta-Alanine	ME545966	239	C00099
Betaine	Betaine	ME545935	247	C00719
Choline	Choline	ME545936	305	C00114
Coenzyme A	Coenzyme A	ME545937	87642	C00010
Cystathionine	Cystathionine	ME545967	439258	C02291
Cytidine monophosphate	CMP	ME545938	6131	C00055
Formate	Formic acid	ME545939	284	C00058
Glucose	Glucose	ME545940	5793	C00221
Glutamate	Glutamic acid	ME545941	33032	C00025
Glutamine	Glutamine	ME545942	5961	C00064
Glycine	Glycine	ME545943	750	C00037
Guanosine	Guanosine	ME545944	6802	C00387
Histidine	Histidine	ME545945	6274	C00135
Isoleucine	Isoleucine	ME545946	6306	C00407
Isovalerate	Isovaleric acid	ME545947	10430	C08262
Lactate	Lactic acid	ME545948	107689	C00186
Leucine	Leucine	ME545949	6106	C00123
Lysine	Lysine	ME545950	5962	C00047
NAD+	NAD+	ME545951	5893	C00003
NADP+	NADP+	ME545952	5886	C00006
Nicotinate	Nicotinic acid	ME545953	938	C00253
Phenylalanine	Phenylalanine	ME545954	6140	C00079
Phosphoenolpyruvic acid	Phosphoenolpyruvic acid	ME545955	1005	C00074
sn-Glycero-3-phosphocholine	sn-Glycero-3-phosphocholine	ME545965	71920	C00670
Succinate	Succinic acid	ME545956	1110	C00042
Sucrose	Sucrose	ME545957	5988	C00089
Threonine	Threonine	ME545958	6288	C00188
Tryptophan	Tryptophan	ME545959	6305	C00078
Tyrosine	Tyrosine	ME545960	6057	C00082
UMP	UMP	ME545961	6030	C00105
Uracil	Uracil	ME545962	1174	C00106
Uridine	Uridine	ME545963	6029	C00299
Valine	Valine	ME545964	6287	C00183
METABOLITES_END
#END